Physician profile
Jose Pinal
NPI 1013098862
$2,444.22
in general payments reported to CMS, 2019-2025
15 companies · $797 in 2025
The $797 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $11.92 · 2021: $130 · 2022: $169 · 2023: $398 · 2024: $654 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,849.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,559.73 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals Lp | $216.77 | 2019-2025 | Breztri, Tezspire, Airsupra |
| Janssen Pharmaceuticals, INC | $182.86 | 2019 | |
| Stryker Corporation | $130.29 | 2021 | |
| Exact Sciences Corporation | $75.03 | 2024-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.64 | 2024-2025 | Jardiance |
| Abbvie INC. | $46.17 | 2024-2025 | |
| Novo Nordisk INC | $35.08 | 2019-2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $25.13 | 2025 | |
| Inogen, INC. | $24.14 | 2025 | |
| Pulmonx Corporation | $21.32 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Verona Pharma, INC. | $19.50 | 2025 | Ohtuvayre |
| Amgen INC. | $17.50 | 2025 | Repatha, Otezla |
| Lundbeck LLC | $16.06 | 2023 | Rexulti |
| Lilly USA, LLC | $15.00 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Pinal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.